Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001203311-21-000038)

Filing Details

Accession Number:: 0001203311-21-000038
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-05-19 19:10:29
Reporting Period:: 2021-05-17

Accepted Time:: 2021-05-19 19:10:29
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1060736	Seagen Inc.	SGEN	Biological Products, (No Disgnostic Substances) (2836)	911874389

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1809717	R Charles Romp	21823 30Th Drive Se Bothell WA 98021	Evp, Commercial	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2021-05-17	334	$145.95	43,890	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

Shares sold pursuant to a 10b5-1 arrangement to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting and 147 shares acquired under the Amended & Restated 2000 Employee Stock Purchase Plan on January 29, 2021.